Skip to main content

Ibrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplants

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Ibrutinib response durable at 1 year in CLL patients who relapsed after allogeneic stem cell transplants

User login

Username

Password

Reset your password

Type	Lead	score